Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology(2017)

Cited 10|Views6
No score
Abstract
Temsirolimus plus adriamycin exhibited an enhanced antitumor effect in HCC and this drug combination might have a potential value in treatment of HCC. Studies are warranted to comprehensively evaluate the efficacy and safety of this regimen in the future.
More
Translated text
Key words
hepatocellular carcinoma,temsirolimus,adriamycin,antitumor effect
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined